{"id":"W1972733729","doi":"10.1016/j.bbmt.2007.12.195","title":"186: Bortezomib Added to High-Dose Cyclophosphamide During Stem Cell Mobilization is Safe and Provides Effective Disease Control in Chemotherapy-Refractory Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Cyclophosphamide; Refractory (planetary science); Chemotherapy; Oncology; Disease control; Internal medicine; Cancer research; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000278445,0.0004059229,0.0008013697,0.0003534462,0.000314794,0.0004120969,0.0003724965,0.0005301721,0.005020523],"category_scores_gemma":[0.0005476186,0.0002088753,0.0003304853,0.0003872163,0.0003472187,0.0003055102,0.0001772293,0.000988675,0.001262899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003431107,"about_ca_system_score_gemma":0.0004992884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005968172,"about_ca_topic_score_gemma":0.001063191,"domain_scores_codex":[0.9998406,0.00005864578,0.00001898414,0.00001867142,0.00002838289,0.00003469806],"domain_scores_gemma":[0.9998187,0.00005142675,0.00005734279,0.00002667448,0.00001089594,0.0000350175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2012297,0.006247079,0.01367196,0.0008951697,0.0006973111,0.002594037,0.0001153556,0.001690026,0.3734384,0.001439802,0.024826,0.3731551],"study_design_scores_gemma":[0.04996465,0.1048132,0.1487291,0.0003031594,0.001678348,0.02428668,0.0001255627,0.007349814,0.5634423,0.001863233,0.09725582,0.0001881328],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806945,0.009713348,0.001331002,0.001172465,0.001068814,0.0001058761,0.0006146383,0.000323322,0.004975926],"genre_scores_gemma":[0.9937929,0.001215799,0.0008822709,0.0003604457,0.0003540724,0.00003474138,0.0006058542,0.00004696386,0.002706933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005020523,"threshold_uncertainty_score":0.01679534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007232027675752443,"score_gpt":0.2353185533616576,"score_spread":0.2280865256859052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}